Unknown

Dataset Information

0

Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in Npc1-Null Cells.


ABSTRACT: Niemann-Pick disease type C (NPC) is an autosomal recessive disorder characterized by abnormal accumulation of free cholesterol and sphingolipids in lysosomes. The iminosugar miglustat, which inhibits hexosylceramide synthesis, is used for NPC treatment, and 2-hydroxypropyl-?-cyclodextrin (HP-?-CD), a cyclic oligosaccharide derivative, is being developed to treat NPC. Moreover, therapeutic potential of 2-hydroxypropyl-?-cyclodextrin (HP-?-CD) was shown in NPC models, although its mechanism of action remains unclear. Here, we investigated the effects of HP-?-CD, HP-?-CD, and their homolog 2-hydroxypropyl-?-cyclodextrin (HP-?-CD) on lipid accumulation in Npc1-null Chinese hamster ovary (CHO) cells compared with those of miglustat. HP-?-CD and HP-?-CD, unlike HP-?-CD, reduced intracellular free cholesterol levels and normalized the lysosome changes in Npc1-null cells but not in wild-type CHO cells. In contrast, miglustat did not normalize intracellular free cholesterol accumulation or lysosome changes in Npc1-null cells. However, miglustat decreased the levels of hexosylceramide and tended to increase those of sphingomyelins in line with its action as a glucosylceramide synthase inhibitor in both Npc1-null and wild-type CHO cells. Interestingly, HP-?-CD and HP-?-CD, unlike HP-?-CD, reduced sphingomyelins in Npc1-null, but not wild-type, cells. In conclusion, HP-?-CD and HP-?-CD reduce the accumulation of sphingolipids, mainly sphingomyelins, and free cholesterol as well as lysosome changes in Npc1-null, but not in wild-type, CHO cells.

PROVIDER: S-EPMC7038050 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC5584846 | BioStudies
| S-EPMC6170477 | BioStudies
| S-EPMC7250861 | BioStudies
| S-EPMC6675466 | BioStudies
| S-EPMC7795151 | BioStudies
| S-EPMC4959104 | BioStudies
| S-EPMC4204776 | BioStudies
| S-EPMC4392250 | BioStudies
| S-EPMC4529815 | BioStudies
| S-EPMC3466002 | BioStudies